Drug Profile
Research programme: anti toll-like receptor peptide - Opsona
Alternative Names: OPN-401Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Opsona Therapeutics
- Class Peptides
- Mechanism of Action Toll-like receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in Ireland (Parenteral)